Signet Financial Management’s Novo Nordisk NVO Stock Holding History

Signet Financial Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,559	Closed	-$306K	–	292
2024 Q4	$306K	Sell	3,559 -1,000	-22%	-$108K	0.04%	228
2024 Q3	$543K	Sell	4,559 -4	-0.1%	-$533	0.07%	187
2024 Q2	$651K	Buy	4,563 +4	+0.1%	+$530	0.09%	174
2024 Q1	$585K	Buy	4,559 +9	+0.2%	+$1.07K	0.08%	185
2023 Q4	$471K	Sell	4,550 -294	-6%	-$29.1K	0.07%	194
2023 Q3	$441K	Hold	4,844	–	–	0.07%	195
2023 Q2	$392K	Hold	4,844	–	–	0.06%	207
2023 Q1	$385K	Sell	4,844 -88	-2%	-$6.24K	0.06%	208
2022 Q4	$334K	Buy	4,932 +382	+8%	+$22.4K	0.06%	215
2022 Q3	$227K	Hold	4,550	–	–	0.04%	226
2022 Q2	$254K	Buy	+4,550	New	+$252K	0.05%	222
2022 Q1	–	Sell	-550	Closed	-$31K	–	973
2021 Q4	$31K	Buy	+550	New	+$29.8K	﹤0.01%	687
2018 Q4	–	Sell	-1,434	Closed	-$34K	–	635
2018 Q3	$34K	Hold	1,434	–	–	0.01%	444
2018 Q2	$33K	Hold	1,434	–	–	0.01%	447
2018 Q1	$35K	Buy	+1,434	New	+$37.6K	0.01%	406

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Signet Financial Management's NVO Position: Q1 2025 in Review

Signet Financial Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 3,559 shares — an estimated $306K sold.

Signet Financial Management first reported a position in NVO in Q1 2018 and held it in 15 quarters. The position peaked at $651K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

Signet Financial Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
Signet Financial Management sold 3,559 Novo Nordisk shares in Q1 2025, an estimated $306K.
Signet Financial Management first reported a position in Novo Nordisk in Q1 2018 and held it in 15 quarters.
Signet Financial Management's Novo Nordisk position peaked at $651K in Q2 2024.
1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Signet Financial Management's 13F filing for Q1 2025, filed 15 Apr 2025.